The impact of the California state lockdown during the COVID-19 pandemic on management of patients with pancreatic ductal adenocarcinoma.
Parisa OviedoShohei BurnsWen-Pin ChenHanna K MandlClaudia RossoNiloofar RadgoudarziAnna CrosettiSteven ZamoraLauren M PerryRichard J BoldAmanda N LaboraTimothy R DonahueAjay MakerJennifer B ValerinJason A ZellRebekah R WhitePublished in: Journal of surgical oncology (2024)
The COVID-19 lockdown did not significantly delay initial presentation, diagnosis, or treatment of newly diagnosed PDAC patients. Time from diagnosis to first treatment was shorter post-lockdown. Reduced healthcare utilization for minor complaints and increased telehealth utilization may have contributed.